Related Articles
Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines
Effect of lanthanum chloride on tumor growth and apoptosis in human ovarian cancer cells and xenograft animal models
Knockdown of long non‑coding RNA LINC00152 increases cisplatin sensitivity in ovarian cancer cells
Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer